Mutated EGFR-IN-1

Mutated EGFR-IN-1 Structure
CAS No.
1421372-66-8
Chemical Name:
Mutated EGFR-IN-1
Synonyms
AZD9291 intermediate;OMT-3;CS-1173;HY-78869;AZD9291 3;AZD9291DA;AZD9291 N-2;AZD9291 int-5;Osimertinib N-2;AZD9291 INT1 N-2
CBNumber:
CB22715656
Molecular Formula:
C25H31N7O
Molecular Weight:
445.56
MOL File:
1421372-66-8.mol
MSDS File:
SDS
Modify Date:
2024/9/25 11:21:29

Mutated EGFR-IN-1 Properties

Boiling point 676.5±65.0 °C(Predicted)
Density 1.21±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: ≥ 75 mg/mL (168.33 mM)
pka 9.07±0.28(Predicted)
form Powder
InChIKey HTNTZPBKKCORTP-UHFFFAOYSA-N
SMILES C1(N(CCN(C)C)C)=CC(OC)=C(NC2=NC=CC(C3C4=C(N(C)C=3)C=CC=C4)=N2)C=C1N

Mutated EGFR-IN-1 Chemical Properties,Uses,Production

Uses

N1-?[2-?(Dimethylamino)?ethyl]?-?5-?methoxy-?N1-?methyl-?N4-?[4-?(1-?methyl-?1H-?indol-?3-?yl)?-?2-?pyrimidinyl]?-?1,?2,?4-?benzenetriamine can be involved as reactant/reagent in "Schizophrenic" self-assembly of dual thermoresponsive block copolymers bearing a zwitterionic and a non-ionic hydrophilic block.

Mutated EGFR-IN-1 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 212)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Bulat Pharmaceutical Pvt Ltd +91-8448085659 +91-8448085660 Haryana, India 123 58 Inquiry
ALS INDIA LIFE SCIENCES +91-8977036379 +91-8977036379 Hyderabad, India 1879 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Ashchemie India 09821323153 Maharashtra, India 30 58 Inquiry
Cangzhou Kangrui Pharma Tech Co. Ltd., +8618632776803 China 733 58 Inquiry
Henan Fengda Chemical Co., Ltd +86-371-86557731 +86-13613820652 China 20290 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
Shanghai Daken Advanced Materials Co.,Ltd +86-371-66670886 China 18656 58 Inquiry

Mutated EGFR-IN-1 Spectrum

Mutated EGFR-IN-1 HY-78869 AZD9291DA HCl salt N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine AZD9291 int-5 N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine 1,2,4-Benzenetriamine, N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]- AZD9291 3 N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine AZD9291 intermediate 4 N1-(2-dimethylaminoethyl)-5-methoxy-N1-methyl-N4-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine N-(2-dimethylamino-ethyl)-2-methoxy-n-methyl-n-[4-(1-methyl-1h-indol-3-yl)-pyrimidin-2-yl]-5-Amino-benzene-1,4-diamine AZD9291 Intermediate1 Mereletinib Intermediates OMT-3 N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)b N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene AZD9291DA N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3- yl)pyrimidin-2-yl)benzene-1,2-triamine Osimertinib intermediate Osimertinib analog Mutated EGFR inhibitor 1 AZD9291 intermediates 3 Osimertinib Intermediate 3 N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-m-ethyl-1H-indol-3-yl)-2-pyrimidi-nyl]-1,2, Mutated EGFR-IN-1 (Osimertinib analog) AZD9291 N-2 AZD91 intermediate CS-1173 Osimertinib Impurity 5 AZD9291 INT1 N-2 1-N-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine AZD9291 intermediate N1- [2- (dimethylamino) ethyl] -5-methoxy-N1- methyl-N4- [4- (1-methyl-1H-indole-3-yl) -2-pyrimidinyl] -1,2,4-phenyltriamine Osimertinib N-2 1421372-66-8 AZD9291 Pharmaceutical intermediate API